Survival of European adolescents and young adults diagnosed with cancer in 2000-07: population-based data from EUROCARE-5.

[1]  U. Dirksen,et al.  Teenagers and young adults with cancer in Europe: from national programmes to a European integrated coordinated project. , 2016, European journal of cancer care.

[2]  J. Rowe,et al.  Acute Myeloid Leukemia in Adolescents and Young Adults: Challenging Aspects , 2014, Acta Haematologica.

[3]  U. Dirksen,et al.  ENCCA WP17-WP7 consensus paper on teenagers and young adults (TYA) with bone sarcomas. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  K. Cooney,et al.  Prostate cancer in young men: an important clinical entity , 2014, Nature Reviews Urology.

[5]  L. Vidal,et al.  Adolescents and young adults with acute lymphoblastic leukemia have a better outcome when treated with pediatric‐inspired regimens: Systematic review and meta‐analysis , 2012, American journal of hematology.

[6]  A. Ferrari,et al.  Rhabdomyosarcoma in adolescents , 2012, Cancer.

[7]  A. Ferrari,et al.  The challenge of access to care for soft tissue sarcomas bridging pediatric and adult age: the Italian pediatric oncology view , 2012, Expert review of anticancer therapy.

[8]  W. Wood,et al.  Malignant hematologic diseases in adolescents and young adults. , 2011, Blood.

[9]  D. Blair,et al.  Unique characteristics of adolescent and young adult acute lymphoblastic leukemia, breast cancer, and colon cancer. , 2011, Journal of the National Cancer Institute.

[10]  D. Lin,et al.  Treatment and survival outcomes in young men diagnosed with prostate cancer , 2009, Cancer.

[11]  J. Coebergh,et al.  Survival of European children and young adults with cancer diagnosed 1995-2002. , 2009, European journal of cancer.

[12]  G. Gatta,et al.  The advantage of women in cancer survival: an analysis of EUROCARE-4 data. , 2009, European journal of cancer.

[13]  C. Bloomfield,et al.  What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. , 2008, Blood.

[14]  R. Barr,et al.  International Working Group on Adolescent/Teenage and Young Adult Oncology , 2008, Pediatric blood & cancer.

[15]  David M. Thomas,et al.  The distinctive biology of cancer in adolescents and young adults , 2008, Nature Reviews Cancer.

[16]  S. Richards,et al.  Adolescents with acute lymphoblastic leukaemia: Outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials , 2007, Pediatric blood & cancer.

[17]  G. Gustafsson,et al.  Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden , 2006, Cancer.

[18]  Eva Steliarova-Foucher,et al.  International Classification of Childhood Cancer, third edition , 2005, Cancer.

[19]  P. Sonneveld,et al.  Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands , 2004, Leukemia.

[20]  P. Babb,et al.  Classification and incidence of cancers in adolescents and young adults in England 1979–1997 , 2002, British Journal of Cancer.

[21]  Hermann Brenner,et al.  Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland. , 2002, International journal of epidemiology.

[22]  Hall,et al.  Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA , 1997, British journal of haematology.

[23]  O. Gefeller,et al.  An alternative approach to monitoring cancer patient survival , 1996 .

[24]  F. Ederer,et al.  The relative survival rate: a statistical methodology. , 1961, National Cancer Institute monograph.

[25]  Silvia Rossi,et al.  Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study. , 2014, The Lancet. Oncology.

[26]  M. Coleman,et al.  Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study. , 2014, The Lancet. Oncology.

[27]  A. Bleyer,et al.  Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975-2000. , 2006 .

[28]  O. Gefeller,et al.  An alternative approach to monitoring cancer patient survival. , 1996, Cancer.